hypertrophic cardiomyopathy obstructive cardiomyopathy
play

Hypertrophic cardiomyopathy/Obstructive cardiomyopathy Anita Deane - PowerPoint PPT Presentation

Hypertrophic cardiomyopathy/Obstructive cardiomyopathy Anita Deane Snr Cardiac Physiologist Apical HCM Apical HCM Apical HCM Lateral/Inferior wall HCM Lat/Inf wall HCM HOCM Hypertrophic obstructive cardiomyopathy HOCM HOCM HOCM


  1. Hypertrophic cardiomyopathy/Obstructive cardiomyopathy Anita Deane Snr Cardiac Physiologist

  2. Apical HCM

  3. Apical HCM

  4. Apical HCM

  5. Lateral/Inferior wall HCM

  6. Lat/Inf wall HCM

  7. HOCM – Hypertrophic obstructive cardiomyopathy

  8. HOCM

  9. HOCM

  10. HOCM

  11. HOCM

  12. HOCM

  13. HOCM

  14. HOCM

  15. HCM prevalence • Common inherited cardiovascular disease. • HCM, 1:500 prevalence in general population. • HCM most common cause of SCD in young people, (<35 years) and athletes. • Autosomal dominant, child has 50% chance of inheritance. • Alterations of MYH7 and MYBPC3 a/c for >80%.

  16. LVOT obstruction Valsalva manoeuvre can alter loading conditions and contractile state of the heart. However, this underestimates gradients compared with exercise, 40% sensitive in predicting exercise induced gradients. Exercise is the most physiological and sensitive method for detecting provocable LVOT obstruction.

  17. Mimics • LVOT obstructive gradient is seen in late systole. • Mitral regurgitation is seen from from early systole.

  18. Other echo features • Elongated MV leaflets sometimes seen • Diastolic dysfunction. • Dilated left atrium. • Over time LV systolic impairment.

  19. Screening/Follow up? Treatment?

  20. Thank you, any questions?

Recommend


More recommend